{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-23-120216","form_type":"8-K","ticker":"MPT","cik":"0001287865","company_name":"MEDICAL PROPERTIES TRUST INC","filed_at":"2023-04-27T23:59:59+00:00","discovered_at":"2026-05-14T18:03:38.275759+00:00","generated_at":"2026-06-16T08:26:25.209874+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"negative","materiality_score":0.8,"calibrated_materiality_score":0.8,"confidence":"high","headline":"MPT Q1 net income $0.05 diluted vs $1.05 YoY, NFFO $0.37; cuts 2023 guidance, declares $0.29 dividend","bullets":["Net income $33M ($0.05/diluted) vs $632M ($1.05) in Q1 2022; includes $90M impairment for hospital sales.","Normalized FFO $222M ($0.37/diluted) vs $282M ($0.47) YoY, driven by no Prospect revenue and asset sales.","Agreed to sell Healthscope portfolio for AUD$1.2B; Prime to repurchase three hospitals for ~$100M in Q3.","2023 guidance revised: net income $0.06-$0.17 per share, NFFO $1.50-$1.61; debt reduction expected ~$1.4B.","Sued Viceroy Research for defamation; regular Q2 dividend of $0.29 per share declared."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-23-120216","json":"https://secwatch.observer/filing/0001193125-23-120216.json","markdown":"https://secwatch.observer/filing/0001193125-23-120216.md","text":"https://secwatch.observer/filing/0001193125-23-120216.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1287865/000119312523120216/0001193125-23-120216-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1287865/000119312523120216/d444501d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-16T08:26:25.209874+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"cf1b455b8f171b703e31104c4b1d98e521837d95","claim":"MEDICAL PROPERTIES TRUST INC reported the first quarter ended March 31, 2023 results: revenue approximately $19.7 billion, net income $33 million ($0.05 per diluted share), EPS $0.05. Guidance reaffirmed.","evidence_excerpt":"facilitate MPT’s conversion of certain existing and future real estate obligations of Prospect into additional managed care equity. The Company has total assets of approximately $19.7 billion, including $13.7 billion of general acute care hospitals, $2.5 billion of behavioral health facilities and $1.7 billion of post-acute facilities. MPT’s portfolio includes 444","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1287865/000119312523120216/0001193125-23-120216-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the first quarter ended March 31, 2023"},{"label":"Revenue","value":"approximately $19.7 billion"},{"label":"Net income","value":"$33 million ($0.05 per diluted share)"},{"label":"EPS","value":"$0.05"},{"label":"Guidance","value":"reaffirmed"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}